$0.76—Stale · unknown old
SET • Last print unknown ago
$0.76—Stale · unknown old
DOD Biotech Public Co., Ltd. specializes in the development and distribution of household and personal care products, primarily in Thailand. The company's competitive position is bolstered by its focus on biotechnology for product innovation, which differentiates its offerings in a crowded market.
DOD Biotech generates revenue through the sale of innovative personal care and household products that leverage biotechnology for enhanced efficacy. The company benefits from strong brand loyalty and a growing consumer preference for eco-friendly and effective products, allowing for premium pricing.
Changes in consumer preferences towards eco-friendly products
Regulatory changes affecting product formulations
Raw material price fluctuations impacting margins
Market expansion efforts in Southeast Asia
Technological disruption in product development
Regulatory changes impacting product safety and efficacy
Intense competition from established global brands
Emerging local brands offering similar products at lower prices
Low return on equity indicating potential inefficiencies
Limited cash reserves affecting ability to invest in growth
moderate - The company's performance is somewhat linked to consumer spending trends, which can be influenced by economic conditions.
Interest rates affect DOD Biotech primarily through consumer spending; higher rates may dampen discretionary spending on personal care products, impacting revenue.
minimal - The company has low debt levels, reducing sensitivity to credit conditions.
value - Investors may be attracted to the company's low valuation metrics despite recent performance challenges.
high - The stock has exhibited significant volatility, with a 1-year return of -40.7%.